Compugen (CGEN) Enterprise Value (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.71% |
| Dec 31, 2025 | -1,239.79% |
| Sep 30, 2025 | -15.28% |
| Jun 30, 2025 | 55.63% |
| Mar 31, 2025 | 81.70% |
| Dec 31, 2024 | -1,003.46% |
| Sep 30, 2024 | 39.24% |
| Jun 30, 2015 | -4,723.02% |
| Mar 31, 2015 | 97.93% |
| Dec 31, 2013 | -28,518.81% |
| Sep 30, 2013 | 99.23% |
| Jun 30, 2013 | -13,362.24% |
| Mar 31, 2013 | 99.50% |
| Dec 31, 2012 | -21,426.37% |
| Sep 30, 2012 | 98.97% |
| Jun 30, 2012 | -9,245.26% |
| Mar 31, 2012 | 99.58% |
| Dec 31, 2011 | -23,698.94% |
| Sep 30, 2011 | 98.73% |
| Jun 30, 2011 | -7,376.77% |
| Mar 31, 2011 | 99.55% |
| Dec 31, 2010 | -392.53% |
| Sep 30, 2010 | 71.01% |
| Jun 30, 2010 | -9,953.95% |
| Mar 31, 2010 | 99.01% |
| Dec 31, 2009 | -229.03% |
| Sep 30, 2009 | 0.00% |